Manufacturing, Cell Culture and Fermentation

Sep 07, 2018
By BioPharm International Editors
New products were developed as next-generation process intensification technologies, MilliporeSigma reports.
Sep 04, 2018
By BioPharm International Editors
A collaboration integrates Sartorius Stedim Biotech’s BIOSTAT STR bioreactors and Repligen’s XCell ATF cell-retention control technology to create simplified, scalable equipment for intensified cell culture.
Aug 01, 2018
BioPharm International
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
Jul 01, 2018
BioPharm International
Late-stage and commercial biomanufacturing pose a challenge to cell-culture processing.
Jun 01, 2018
BioPharm International
Transcriptomics plays a role in influencing the production of recombinant therapeutics in microbial and mammalian hosts.
Jun 01, 2018
BioPharm International
Higher cell titers and cell densities have posed a challenge to cell harvesting, a crucial step in biologics manufacturing.
May 16, 2018
By BioPharm International Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
Apr 20, 2018
By BioPharm International Editors
The new platform is expected to speed up cell line development.
Apr 05, 2018
By BioPharm International Editors
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
Mar 19, 2018
By BioPharm International Editors
Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.
native1_300x100
lorem ipsum